Empagliflozin and metformin synergy in proximal tubular epithelial cells: does the combination alleviates hyperglycaemia-induced metabolic stress?

Investor logo

Warning

This publication doesn't include Faculty of Education. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

GALUŠKA David PÁCAL Lukáš CHALÁSOVÁ Katarína KAŇKOVÁ Kateřina

Year of publication 2023
Type Conference abstract
MU Faculty or unit

Faculty of Medicine

Citation
Description Metformin remains the drug of first choice in type 2 diabetes mellitus (T2DM) worldwide since its beneficial metabolic effects are known for a long time.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.